{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:13:39Z","timestamp":1790565219378,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive lipid storage disease caused by a mutation in the\n                      <jats:italic>CYP27A1<\/jats:italic>\n                      gene. Due to the disruption of bile acid synthesis leading to cholesterol and cholestanol accumulation, CTX manifests as premature cataracts, chronic diarrhea, and intellectual disability in childhood and adolescence. This report presents a case of CTX with an unusual phenotype of behavioral variant frontotemporal dementia (bvFTD) in middle age.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 60-year-old woman presented with behavioral and personality changes. She showed disinhibition, such as hoarding and becoming aggressive over trifles; compulsive behavior, such as closing doors; apathy; and dietary change. The patient showed a progressive cognitive decline and relatively sparing memory and visuospatial function. She had hyperlipidemia but no family history of neurodegenerative disorders. Initial fluid-attenuated inversion recovery (FLAIR) images showed a high signal in the periventricular area, and brain spectroscopy showed hypoperfusion in the frontal and temporal lobes, mimicking bvFTD. However, on physical examination, xanthomas were found on both the dorsum of the hands and the Achilles tendons. Hyperactive deep tendon reflexes in the bilateral biceps, brachioradialis, and knee and positive Chaddock signs on both sides were observed. Four years later, FLAIR images showed symmetrical high signals in the bilateral dentate nuclei of the cerebellum. Her serum cholestanol (12.4 mg\/L; normal value \u22646.0) and 7\u03b1,12\u03b1-dihydroxycholest-4-en-3-one (0.485 nmol\/mL; normal value \u22640.100) levels were elevated. A novel likely pathogenic variant (c.1001T&amp;gt;A, p.Met334Lys) and a known pathogenic variant (c.1420C&amp;gt;T, p.Arg474Trp) of the\n                      <jats:italic>CYP27A1<\/jats:italic>\n                      gene were found in trans-location. The patient was diagnosed with CTX and prescribed chenodeoxycholic acid (750 mg\/day).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This report discusses the case of a middle-aged CTX patient with an unusual phenotype of bvFTD. A novel likely pathogenic variant (c.1001T&amp;gt;A, p.Met334Lys) was identified in the\n                      <jats:italic>CYP27A1<\/jats:italic>\n                      gene. Early diagnosis is important because supplying chenodeoxycholic acid can prevent CTX progression.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2023.1131888","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T08:19:13Z","timestamp":1678177153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Case report: Cerebrotendinous xanthomatosis with a novel mutation in the CYP27A1 gene mimicking behavioral variant frontotemporal dementia"],"prefix":"10.3389","volume":"14","author":[{"given":"Min Young","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Jin","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Lim","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Hyun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Young","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Yeon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13023-014-0179-4","article-title":"Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management","volume":"9","author":"Nie","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI110742","article-title":"Role of the 26-hydroxylase in the biosynthesis of bile acids in the normal state and in cerebrotendinous xanthomatosis. An in vivo study","volume":"71","author":"Bjorkhem","year":"1983","journal-title":"J Clin Invest."},{"key":"B3","first-page":"83","article-title":"Cerebrotendinous xanthomatosis\u2013A case report of two siblings","volume":"29","author":"Kim","year":"1988","journal-title":"Seoul J Med."},{"key":"B4","first-page":"775","article-title":"A Case of preeumect Cerebrotedinous Xanthomatosis","volume":"29","author":"Lee","year":"1988","journal-title":"J Korean Ophthalmol Soc."},{"key":"B5","first-page":"783","article-title":"A case of cerebrotendinous xanthomatosis","volume":"29","author":"Lee","year":"1988","journal-title":"J Korean Ophthalmol Soc."},{"key":"B6","first-page":"460","article-title":"A case of cerebrotendinous xanthomatosis","volume":"22","author":"Park","year":"1998","journal-title":"Ann Rehabil Med."},{"key":"B7","first-page":"94","article-title":"A case of cerebrotendinous xanthomatosis","volume":"18","author":"Jung","year":"2000","journal-title":"J Korean Neurol Assoc."},{"key":"B8","first-page":"1261","article-title":"A case of cerebrotendinous xanthomatosis","volume":"40","author":"Lee","year":"2002","journal-title":"Korean J Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejmg.2011.08.003","article-title":"Three siblings with cerebrotendinous xanthomatosis: a novel mutation in the CYP27A1 gene","volume":"55","author":"Suh","year":"2012","journal-title":"Eur J Med Genet."},{"key":"B10","first-page":"215","article-title":"Cerebrotendinous xanthomatosis with spinal cord syndrome","volume":"32","author":"Yoo","year":"2014","journal-title":"J Korean Neurol Assoc."},{"key":"B11","volume-title":"Seoul Neuropsychological Screening Battery","author":"Kang","year":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0022-2275(20)40096-3","article-title":"Identification of new mutations in sterol 27-hydroxylase gene in Japanese patients with cerebrotendinous xanthomatosis (CTX)","volume":"35","author":"Kim","year":"1994","journal-title":"J Lipid Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp.67.2.195","article-title":"Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism","volume":"67","author":"Wakamatsu","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1046\/j.1365-2796.2002.01033.x","article-title":"Cerebrotendinous xanthomatosis: molecular characterization of two Scandinavian sisters","volume":"252","author":"Rystedt","year":"2002","journal-title":"J Intern Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1440-1789.2006.00739.x","article-title":"Cerebrotendinous xanthomatosis with a compound heterozygote mutation and severe polyneuropathy","volume":"27","author":"Wang","year":"2007","journal-title":"Neuropathology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.clineuro.2012.01.032","article-title":"A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 gene","volume":"114","author":"Koyama","year":"2012","journal-title":"Clin Neurol Neurosurg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s10038-017-0389-4","article-title":"Nationwide survey on cerebrotendinous xanthomatosis in Japan","volume":"63","author":"Sekijima","year":"2018","journal-title":"J Hum Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/brain\/123.5.908","article-title":"Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis","author":"Verrips","year":"2000","journal-title":"Brain 123 (Pt 5)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1023\/A:1010564920930","article-title":"Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27)","volume":"24","author":"Sugama","year":"2001","journal-title":"J Inherit Metab Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ajmg.a.30797","article-title":"Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype","author":"Guyant-Marechal","year":"2005","journal-title":"Am J Med Genet A 139A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s003300050964","article-title":"MRI of the brain in cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease)","volume":"10","author":"Vanrietvelde","year":"2000","journal-title":"Eur Radiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2377-10-59","article-title":"Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations","volume":"10","author":"Chang","year":"2010","journal-title":"BMC Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1038\/tp.2013.76","article-title":"Psychiatric manifestations in cerebrotendinous xanthomatosis","volume":"3","author":"Fraidakis","year":"2013","journal-title":"Transl Psychiatry."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jacl.2016.05.005","article-title":"Tendon xanthomas: not always familial hypercholesterolemia","volume":"10","author":"Koopal","year":"2016","journal-title":"J Clin Lipidol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0190-9622(88)70157-7","article-title":"Dermal, subcutaneous, and tendon xanthomas: diagnostic markers for specific lipoprotein disorders","volume":"19","author":"Cruz","year":"1988","journal-title":"J Am Acad Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/jcp.2007.049775","article-title":"Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis","volume":"61","author":"Kidambi","year":"2008","journal-title":"J Clin Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3174\/ajnr.A5138","article-title":"Dentate update: imaging features of entities that affect the dentate nucleus","volume":"38","author":"Bond","year":"2017","journal-title":"AJNR Am J Neuroradiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/archneur.1992.00530290051011","article-title":"Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid","volume":"49","author":"Mondelli","year":"1992","journal-title":"Arch Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1468-1331.2011.03439.x","article-title":"Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey","volume":"18","author":"Pilo-De-La-Fuente","year":"2011","journal-title":"Eur J Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00415-012-6630-3","article-title":"Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid","volume":"260","author":"Ginanneschi","year":"2013","journal-title":"J Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/0026-0495(93)90205-3","article-title":"Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis","volume":"42","author":"Kuriyama","year":"1993","journal-title":"Metabolism."},{"key":"B33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/08830738030180091001","article-title":"Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy","volume":"18","author":"Federico","year":"2003","journal-title":"J Child Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"100078","DOI":"10.1016\/j.jlr.2021.100078","article-title":"Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis","volume":"62","author":"Hoflinger","year":"2021","journal-title":"J Lipid Res."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1131888\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T08:19:20Z","timestamp":1678177160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1131888\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":34,"alternative-id":["10.3389\/fneur.2023.1131888"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1131888","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"article-number":"1131888"}}